早期痴呆认知辅助工具对照常规治疗试验(DESCANT)研究方案
DESCANT是一项多中心实用性随机对照试验,计划纳入360对轻中度痴呆患者及其照护者,比较家庭记忆辅助工具、培训与支持干预与常规治疗的临床及成本效果。主要结局为布里斯托尔日常生活活动量表,随访至26周,并辅以定性及过程评估。
要点
- 评价家庭记忆辅助工具、培训与支持对轻中度痴呆患者及照护者的效果
- 计划随机分配360对患者-照护者,对照为常规治疗
- 主要结局为布里斯托尔日常生活活动量表,随访13周和26周
核心结论
- 该方案旨在评估DESCANT干预相比常规治疗的临床与成本效果,若干预有效且成本适中,则更可能纳入主流实践。
研究设计与样本
- 多中心实用性随机对照试验,先行可行性研究和内部预试验,计划随机分配360对轻中度痴呆患者及其照护者至DESCANT干预组或常规治疗组。
- 在基线、13周和26周评估参与者,主要结局为布里斯托尔日常生活活动量表。
- 同时开展定性研究和过程评估,以评估实施过程并识别与变异相关的背景因素。
关键数值与推荐
- 计划随机分配360对轻中度痴呆患者及其照护者。
- 主要结局指标为布里斯托尔日常生活活动量表。
- 随访评估时间为基线、13周和26周。
临床怎么用
- 若DESCANT干预被证实具有临床和成本效果,其适度的性质和成本将增加被纳入主流实践的可能性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is a growing need for an evidence-based approach to home support for people with dementia and their carers following diagnosis but research on the effectiveness and cost-effectiveness of different approaches is sparse. The Dementia Early Stage Cognitive Aids New Trial (DESCANT) will evaluate the clinical and cost-effectiveness of a range of memory aids, training and support to people with mild to moderate dementia and their carers at home and compares that intervention with treatment as usual. METHODS/DESIGN: This is a multi-site, pragmatic randomised trial preceded by a feasibility study and internal pilot. We aim to allocate at random 360 pairs comprising a person with mild to moderate dementia and an identified carer between the DESCANT intervention and treatment as usual. We assess participants at baseline, 13 and 26 weeks. The primary outcome measure is the Bristol Activities of Daily Living Scale; other participant outcomes include cognition, quality of life, activities of daily living and social networking; carer outcomes include quality of life, sense of competence and mental health. To enhance this quantitative evaluation we are conducting a qualitative component and a process evaluation to assess the implementation process and identify contextual factors associated with variation. DISCUSSION: The DESCANT intervention reflects current policy to enhance the capabilities of people with dementia after diagnosis and their carers. If it is clinically and cost-effective, its modest nature and cost will enhance the likelihood of it being incorporated into mainstream practice. TRIAL REGISTRATION: Current Controlled Trials, ISRCTN12591717 . Registered on 29 July 2016. Protocol number: 31288: North West - Haydock Research Ethics Committee, 20/06/2016, ref.: 16/NW/0389.
引用
- Chester H, Clarkson P, Davies L, et al. Cognitive aids for people with early stage dementia versus treatment as usual (Dementia Early Stage Cognitive Aids New Trial (DESCANT)): study protocol for a randomised controlled trial. Trials. 2018. PMID: 30305153. doi:10.1186/s13063-018-2933-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。